Mammalian cells accumulate iron from ferric citrate or ferric nitrilotriacetate through the activity of a transferrin-independent iron transport system [Sturrock, Alexander, Lamb, Craven and Kaplan (1990) J. Biol. Chem. 265, 3139-3145]. The uptake system might recognize and transport ferric-anion complexes, or cells may reduce ferric iron at the surface and then transport ferrous iron. To distinguish between these possibilities we exposed cells to either [59Fe]ferric citrate or ferric [14C]citrate and determined whether accumulation of iron was accompanied by the obligatory accumulation of citrate. In HeLa cells and human skin fibroblasts the rate of accumulation of iron was three to five times greater than that of citrate. Incubation of fibroblasts with ferric citrate or ferric ammonium citrate resulted in an enhanced accumulation ofiron and citrate; the molar ratio of accumulation approaching unity. A similar rate of citrate accumulation, however, was observed when ferric citrate-incubated cells were
INTRODUCTION
Mammalian cells accumulate iron by either of two transport systems. The first system involves the binding of diferric transferrin [Tf(Fe)2] to high-affinity receptors. The Tf(Fe)2-receptor complex is internalized into an acidic endosome where iron is released from the receptor-bound transferrin (Tf). The release, and subsequent transport of iron out of the endosome, results from the interplay of pH (Klausner et al., 1983; Dautry-Varasat et al., 1983) , receptor binding (Bali et al., 1991; Sipe and Murphy, 1991) and possibly a reductase (Nunez et al., 1990) . While Tf receptors may be found on all cell types they are most prevalent on dividing cells and erythrocyte precursors. The second iron transport system is a Tf-independent transport system, present on cell surfaces, which mediates the accumulation of low-molecular-mass iron-anion complexes (Wheby and Crosby, 1963; Brissot et al., 1985; Basset et al., 1986; Wright et al., 1986; Richardson and Baker, 1992; Inman and WesslingResnick, 1993) . In contrast to the Tf-based transport system, the activity of the Tf-independent system in some cell types is increased by the presence of extracellular iron (Kaplan et al., 1991) . The regulation and tissue distribution of this system suggests a scavenger function for the removal of non-Tf-bound iron (Craven et al., 1987) . Non-Tf-bound iron occurs in a number of iron-overload diseases, most commonly hereditary haemochromatosis (Grootveeld et al., 1989) and the rarer disorder, atransferrinaemia (Craven et al., 1987) . This transport system is most active in organs, but is nearly non-existent in erythroid precursors (Craven et al., 1987) . Analysis of the chemical form of non-Tf iron present in the plasma of patients exposed to [14C] citrate alone. Further studies demonstrated the independence of iron and citrate accumulation: addition of unlabelled citrate to cells decreased the uptake of labelled citrate without affecting the accumulation of 59Fe; iron uptake was decreased by the addition of ferrous chelators whereas the uptake of citrate was unaffected; reduction of ferric iron by ascorbate increased the uptake of iron but had no effect on the uptake of citrate. When HeLa cells were depleted of calcium, iron uptake decreased, but there was little effect on citrate uptake. These results indicate that transport of iron does not require the obligatory transport of citrate and vice versa. The mammalian transferrin-independent iron transport system appears functionally similar to iron transport systems in both the bacterial and plant kingdoms which require the activities of both a surface reductase and a ferrous metal transporter.
with hereditary haemochromatosis suggested that a significant fraction was in the form of ferric citrate (Grootveeld et al., 1989) . Studies using cultured mammalian cells demonstrated that the Tf-independent transport system could mediate iron accumulation when cells were presented with ferric citrate (Basset et al., 1986; Kaplan et al., 1991; Inman and Wessling-Resnick, 1993) .
A number of non-mammalian species can accumulate iron from ferric citrate. These organisms, which include plants, bacteria and fungi, reduce ferric citrate at the cell surface, generating ferrous iron which is then transported by a ferrous iron transport system (for review see Winkelmann et al., 1987) . A ferrireductase may also be present on the surface ofmammalian cells (Morley and Bezkorovainy, 1985; Sun et al., 1987) , and it has been suggested that mammalian cells do not accumulate ferric iron, but rather accumulate the reduced form, ferrous iron (Thorstensen, 1988 
MATERIALS AND METHODS Cells
HeLa cells and human skin fibroblasts were cultured and maintained as described previously (Kaplan et al., 1991 2) with the specified concentrations of ferric citrate. Incubations were performed at either 37°C or 0°C for specified periods of time. Uptake measured at 0°C is subtracted from that measured at 37 'C. In Figure 3 we have included the 0 'C measurements to give an appreciation of what is essentially non-specific uptake. The cells were washed with ice-cold phosphate-buffered saline, and solubilized in 0.1 0% Triton X-100. Radioactivity of 59Fe-containing samples was determined in a Packard gamma counter. The radioactivity of 14C-containing samples was determined in a Packard liquidscintillation counter, using Optifluor (Packard Instrument Co.) as the fluor. Uptake is expressed as femtomoles (fmol) of iron, or citrate/jg of cell protein. Protein determinations were performed using the procedure of Lowry et al. (1951) with BSA as a standard. All experiments were performed multiple times and the data is expressed as mean+ S.E.M. [14C]citrate uptake above that observed when cells were incubated with [14C]citrate alone. Based on the stoichiometry of chelation we would expect a ratio of uptake of iron to citrate of either 1: 1 or 1 :2 if ferric citrate was accumulated as a complex (Hussein et al., 1981) . In addition, the preparation of ferric citrate required that cells be exposed to a concentration of citrate that is 5-fold higher than that of iron (cf. Materials and methods section (Figure 2 ). At these concentrations citrate may be forming ferric citrate complexes with trace quantities of iron present in MEM, allowing these complexes to compete for uptake with the radiolabelled complexes.
RESULTS
Previously we reported that exposure ofhuman skin fibroblasts to ferric ammonium citrate (FAC) resulted in a marked increase in the activity of the Tf-independent iron transport system (Kaplan et al., 1991) . We therefore examined the ability of FAGexposed fibroblasts to accumulate [14C]citrate. As expected, FAGexposed cells showed an enhanced accumulation of59Fe (compare Figure lb to Figure 3 ; cf. Kaplan et al., 1991 (6) 14 (1) 229 (15) 7 (1) 294 (39) 62 (5) 528 (30) 68 (9) 465 (44) 6 (1) 201 (24) Table 2 addition of ascorbate markedly increases the uptake of iron and reduces the uptake of citrate.
We, and others, have described a number of conditions which affect the activity of the Tf-independent iron transport system. If there is a co-ordinate accumulation of citrate with iron, then we predict that treatments which affect the accumulation of iron should similarly affect the accumulation of citrate. Accumulation of iron by the Tf-independent iron transport system, particularly in perfused rat liver and cultured HeLa cells, is dependent on the presence of extracellular Ca2+ (Wright et al., 1986; Sturrock et al., 1990) . Incubation of HeLa cells in Ca2+-free medium (Hanks' balanced salt solution, HBSS) with [59Fe]ferric citrate results in a decreased rate of accumulation of 59Fe (Table 3 ). There was, however, an increase in the uptake of [14C]citrate both in the presence or absence of iron.
DISCUSSION
Studies have suggested the presence of a plasma membrane ferrireductase activity on mammalian cells. This activity has been reported to reduce extracellular ferricyanide and extracellular Tf(Fe)2, and may be involved in an internalization-independent iron accumulation pathway (Sun et al., 1987;  Thorstensen, 1988) . The interpretation of these experiments has been challenged on both experimental and theoretical grounds (Thorstensen and Aisen, 1990) . To determine if the Tf-independent transport system requires a surface reductase activity, we examined whether cells exposed to ferric citrate exhibited obligatory uptake of iron and citrate. Because of the low affinity of citrate for Fe(II) (Hamm et al., 1954) , if ferric citrate is reduced at the cell surface, then due to the low affinity of Fe(II) for citrate the iron-chelator complex should dissociate at the cell surface and the stoichiometry of accumulation of radiolabelled iron and citrate would not reflect the molar ratio of the two in the chelate. Similar approaches were used to demonstrate the presence and function of surface ferrireductase activity in bacteria (Hussein et al., 1981) and plants (Romheld and Marschner, 1983) .
If iron citrate was accumulated as a complex we expected to see an accumulation of iron: citrate of either 1: 1 or 1: 2, based on the reported stoichiometry of ferric citrate chelation (Hussein et al., 1981) . The method of preparation of ferric citrate resulted in the exposure of cells to a greater concentration of citrate than iron. In HeLa cells and fibroblasts, iron was accumulated at a rate that was 3-5-fold greater than that of citrate. This result is consistent with the involvement of a reductase but other alternatives are possible. One possibility is that 59Fe is accumulated by a ligand-transfer reaction: Fe(III) is transferred from citrate (or NTA) to an Fe(III)-binding moiety. Membrane proteins or lipids with Fe(III)-binding capacity have been reported (Raja et al., 1987; Teichman and Stremmel, 1990; Conrad et al., 1990) . The effect of BPS or ferrozine, impermeant Fe(II) chelators, makes this alternative unlikely: they inhibit 59Fe accumulation without affecting the accumulation of [14C]citrate. Addition of preformed BPS-Fe complexes had little effect on the uptake of 59Fe, indicating that it is the chelating activity of BPS that is responsible for inhibition of uptake rather than BPS-Fe affecting the transporter per se. Further, the ability of BPS or ferrozine to chelate iron is dependent upon cells being incubated at 37 'C. The rate of formation of BPS-Fe(II) or ferrozine-Fe(II) complexes in the absence of cells, or in the presence of cells incubated at 0 'C, was not detectable during the measurement period. If a ligand-transfer reaction were involved it is unlikely that the Fe(II)-chelating activity of BPS would inhibit iron transport. These results are more consistent with Fe(III) being reduced to Fe(II) on the cell surface, prior to transport, where it is accessible to the action of BPS.
Previously we demonstrated that exposure ofcells, particularly fibroblasts, to iron salts resulted in an increase in iron accumulation (Kaplan et al., 1991 The studies presented here suggest that uptake of iron by the Tf-independent transport system requires at least two steps; reduction at the cell surface and accumulation of ferrous iron. In this regard the mammalian Tf-independent transport systems is analogous to iron-transport systems described in bacteria, plants and fungi. Throughout the phylogenetic tree there appear to be two conserved iron accumulation systems, one of which involves the secretion and re-accumulation of iron chelators, secretion of siderophores being the paradigm. The second mechanism involves the reduction of ferric to ferrous iron, which is then transported across cell membranes. Reduction of Fe(III) to Fe(II) can occur by either of two routes: secretion of molecules with reducing potential, such as phenols, or the direct addition of an electron. We have not been able to demonstrate that fibroblasts secrete molecules with reducing potential, which suggests that Fe(III) reduction is mediated by direct electron transfer. This conclusion leads to the inference that transmembrane iron transport may involve movement of iron through an aqueous channel. The requirement for iron in the ferrous form might result from the near insolubility of ferric iron in aqueous solutions.
In the Tf-dependent iron-uptake system, iron is released from internalized Tf(Fe)2 within the endosomal apparatus. While ferric iron may be released from Tf, reduction of iron may be required for transport out of the endosome (Nunez et al., 1990) . Based on these observations the Tf-mediated transport system may represent an adaptation of a reduction-based ferrous transport system. These results further suggest that while iron may be transported in biological fluids as Fe(III), chelated to either citrate or Tf, iron transport across membranes requires reduction to Fe(II).
